Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Revue Medicale Suisse|July 15, 2011
[What strategy for the screening of coronary artery disease in type 1 diabetes?]S Comte-Perret, J RuizPharmacoeconomics|July 18, 2001
International validation of the CLAU-S quality-of-life questionnaire for use in patients with intermittent claudicationP Marquis, S Comte, P LehertPresse Medicale (Paris, France : 1983)|February 23, 1999
[Changes in prescription patterns for peripheral and cerebral vasoactive drugs before and after establishing prescription standards in France]F Vuittenez, E Guignard, S ComteJournal of Hazardous Materials|July 6, 2007
Biosorption properties of extracellular polymeric substances (EPS) towards Cd, Cu and Pb for different pH valuesS Comte, G Guibaud, M BauduJournal Des Maladies Vasculaires|May 11, 2000
[Intermittent claudication and quality of life. Psychometric validation of the French version of the CLAU-S questionnaire]H Boccalon, P Lehert, S ComtePharmacoeconomics|December 8, 1997
Peripheral arterial obliterative disease. Cost of illness in FranceA Montron, E Guignard, A Pelc, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1985
[Prediction and prognosis of diabetes incidence in treated hypertensive patients]A Froment, S Comte, E Guillaume, et al.Bulletin Du Cancer|October 2, 2001
[Epidemiology and costs of lung cancer in France]M D Zélicourt, B Detournay, S Comte, et al.Journal Des Maladies Vasculaires|September 1, 1999
[Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance]N Rolland, T Lebrun, S Comte, et al.Journal of Cardiovascular Pharmacology|January 1, 1994
Naftidrofuryl in intermittent claudication: a retrospective analysisP Lehert, S Comte, S Gamand, et al.Pageof 2